ATH 11.1% 0.5¢ alterity therapeutics limited

ApoE and mitochondrion biogenesis explaining AD

  1. 2,698 Posts.
    lightbulb Created with Sketch. 941
    . 2020 May 26;10.1212/WNL.0000000000009582.
    doi: 10.1212/WNL.0000000000009582. Online ahead of print.

    Effect of ApoE Isoforms on Mitochondria in Alzheimer Disease

    Affiliations

    Abstract

    Objective: To test the hypothesis that ApoE isoforms affect mitochondrial structure and function that are related to cognitive impairment in Alzheimer disease (AD), we systematically investigated the effects of ApoE isoforms on mitochondrial biogenesis and dynamics, oxidative stress, synapses, and cognitive performance in AD.

    Methods: We obtained postmortem human brain tissues and measured proteins that are responsible for mitochondrial biogenesis (peroxisome proliferator-activated receptor-gamma coactivator-1α [PGC-1α] and sirtuin 3 [SIRT3]), for mitochondrial dynamics (mitofusin 1 [MFN1], mitofusin 2 [MFN2], and dynamin-like protein 1 [DLP1]), for oxidative stress (superoxide dismutase 2 [SOD2] and forkhead-box protein O3a [Foxo3a]), and for synapses (postsynaptic density protein 95 [PSD95] and synapsin1 [Syn1]). A total of 46 cases were enrolled, including ApoE-ɛ4 carriers (n = 21) and noncarriers (n = 25).

    Results: Levels of these proteins were compared between ApoE-ɛ4 carriers and noncarriers. ApoE-ɛ4 was associated with impaired mitochondrial structure and function, oxidative stress, and synaptic integrity in the human brain. Correlation analysis revealed that mitochondrial proteins and the synaptic protein were strongly associated with cognitive performance.

    Conclusion: ApoE isoforms influence mitochondrial structure and function, which likely leads to alteration in oxidative stress, synapses, and cognitive function. These mitochondria-related proteins may be a harbinger of cognitive decline in ApoE-ɛ4 carriers and provide novel therapeutic targets for prevention and treatment of AD.


 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(11.1%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $177.1K 43.22M

Buyers (Bids)

No. Vol. Price($)
5 6530000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 61097700 52
View Market Depth
Last trade - 16.10pm 19/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 12.5 %)
Open High Low Volume
0.4¢ 0.5¢ 0.4¢ 23124792
Last updated 15.14pm 19/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.